Machine Learning-Based Prediction of Tumor Recurrence or Progression in Patients with Non-Functioning Pituitary Adenomas
Abstract Background Despite advances in surgical technique, postoperative tumor recurrence or progression (R/P) remains a major challenge among patients with clinically non-functioning pituitary adenomas (NFPA). Reliable tools for individualized R/P risk stratification are limited. Objective To develop and evaluate machine learning (ML) models that integrate clinical, immunohistochemical, and radiomic features based on preoperative MRI towards predicting tumor R/P in patients with NFPA who underwent pituitary surgery. Methods We retrospectively analyzed data of patients with NFPA who underwent their first pituitary operation at Massachusetts General Hospital between 2005–2019, had preoperative postcontrast MRI images available, and ≥3 months of follow-up and conducted an exploratory multimodal modelling analysis. Supervised ML models combining clinical and radiomic features were then trained to predict R/P and were internally evaluated using cross-validation. SHAP analysis was used to identify predictors of R/P. Results 537 patients met inclusion criteria (median age: 58 yr, range: 18–92 yr; 59% male). Overall, 120 patients (22%) experienced R/P during a median follow-up of 74 months. Median R/P-free survival was 170 months. Six ML models were evaluated, wherein TabPFN-based models outperformed others (AUROC: 0.687). Younger age at diagnosis, larger tumor size, higher Ki 67 index, cavernous sinus invasion, male sex, and positive immunostaining for pituitary hormones were predictors of R/P. First order radiomic features also contributed to the prediction of R/P in several models. Conclusions The TabPFN model best predicted tumor R/P in the presence cohort. Prospective studies are needed to confirm and extend the present findings.
Authors
- Masaaki Mikamoto (ORCID: https://orcid.org/0009-0001-6205-9206)
- Ukasha Habib
- Pamela S. Jones (ORCID: https://orcid.org/0000-0002-4573-3641)
- Nicholas A. Tritos (ORCID: https://orcid.org/0000-0001-8867-607X)
- Karen Klahr Miller (ORCID: https://orcid.org/0000-0001-9438-2449)
- Albert Eusik Kim (ORCID: https://orcid.org/0000-0003-2359-6209)
- Brooke Swearingen (ORCID: https://orcid.org/0000-0003-2945-7912)
- Christopher P. Bridge (ORCID: https://orcid.org/0000-0002-2242-351X)
- Otto Rapalino
Institutions
- Massachusetts General Hospital (US)
- Nakamura Memorial Hospital (JP)
- Athinoula A. Martinos Center for Biomedical Imaging (US)
Publication Details
- Journal
- Journal of the Endocrine Society
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1210/jendso/bvag268
- Primary Topic
- Pituitary Gland Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00